Thieno[3,2-b]pyrrole-5-carboxamides as New Reversible Inhibitors of Histone Lysine Demethylase KDM1A/LSD1. Part 2: Structure-Based Drug Design and Structure–Activity Relationship

2017 ◽  
Vol 60 (5) ◽  
pp. 1693-1715 ◽  
Author(s):  
Paola Vianello ◽  
Luca Sartori ◽  
Federica Amigoni ◽  
Anna Cappa ◽  
Giovanni Fagá ◽  
...  
Keyword(s):  
Drug Design ◽  
Structure Activity Relationship ◽  
Activity Relationship ◽  
Structure Based Drug Design ◽  
Reversible Inhibitors ◽  
Structure Activity ◽  
Histone Lysine ◽  
Histone Lysine Demethylase ◽  
Lysine Demethylase

scholarly journals Structure-Activity Relationship Studies on (R)-PFI-2 Analogues as Inhibitors of Histone Lysine Methyltransferase SETD7

ChemMedChem ◽  
2018 ◽  
Vol 13 (14) ◽  
pp. 1405-1413 ◽  
Author(s):  
Danny C. Lenstra ◽  
Eddy Damen ◽  
Ruben G. G. Leenders ◽  
Richard H. Blaauw ◽  
Floris P. J. T. Rutjes ◽  
...  
Keyword(s):  
Structure Activity Relationship ◽  
Activity Relationship ◽  
Structure Activity ◽  
Histone Lysine ◽  
Histone Lysine Methyltransferase ◽  
Lysine Methyltransferase

ChemInform Abstract: ARA-CYTIDINE ACYLATES, USE OF DRUG DESIGN PREDICTORS IN STRUCTURE-ACTIVITY RELATIONSHIP CORRELATION

1975 ◽  
Vol 6 (29) ◽  
pp. no-no
Author(s):  
W. J. WECHTER ◽  
M. A. JOHNSON ◽  
C. M. HALL ◽  
D. T. WARNER ◽  
A. E. BERGER ◽  
...  
Keyword(s):  
Drug Design ◽  
Structure Activity Relationship ◽  
Activity Relationship ◽  
Structure Activity
Sign in / Sign up

Export Citation Format

Share Document